Chronic inflammation, obesity, high blood pressure, high cholesterol, and some medications may increase heart risk in autoimmune patients
As we stand on the cusp of breakthroughs in obesity treatment, GLP-1 agonists appear poised to play a significant role in shaping the future landscape of weight management strategies
When injecting, go slowly and steadily, keeping the needle still while its in your skin
While the results of the trial are dramatic, the fact is that before all the noise around GLP-1s, it was known that even modest weight-loss improved obesity-related conditions and that this had had no negative impact on the MedTech market, as illustrated below
While additional research is needed to identify specific dietary patterns that maximize treatment efficacy, a patient-centered approach should take into account the individual's food and cultural preferences, socioeconomic barriers to healthy food access and diet quality